SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-20-021361
Filing Date
2020-01-31
Accepted
2020-01-31 16:20:33
Documents
2
Group Members
CASPER BREUMLENE SKOLE

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d880696dsc13ga.htm SC 13G/A 68663
2 EX-99.1 d880696dex991.htm EX-99.1 4763
  Complete submission text file 0001193125-20-021361.txt   75065
Mailing Address SCHERFIGSVEJ 7 COPENHAGEN G7 DK-2100
Business Address SCHERFIGSVEJ 7 COPENHAGEN G7 DK-2100 4540307375
Lundbeckfond Invest A/S (Filed by) CIK: 0001591046 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Subject) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90168 | Film No.: 20565337
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences